David Becerro-Recio

Mr. David Becerro-Recio

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
DBDavid Becerro-Recio
David Becerro-Recio
JGJavier González-Miguel
Javier González-Miguel
AUAlberto Ucero
Alberto Ucero
JSJavier Sotillo
Javier Sotillo
AMALVARO MARTINEZ-MORENO
ALVARO MARTINEZ-MORENO
MSMar Siles-Lucas
Mar Siles-Lucas
Excretory/secretory products released by helminth parasites have been widely studied for their diagnostic utility, immunomodulatory properties, as well as for their use as vaccines. Due to their location at the host/parasite interface, the characterization of parasite secretions is important to unravel the molecular interactions governing the relationships between helminth parasites and their hosts. In this study, the excretory/secretory products from adult worms of the trematode Fasciola hepatica (FhES) were employed in a combination of two-dimensional electrophoresis, immunoblot and mass spectrometry, to analyze the immune response elicited in sheep during the course of an experimental infection. Ten different immunogenic proteins from FhES recognized by serum samples from infected sheep at 4, 8, and/or 12 weeks post-infection were identified. Among these, different isoforms of cathepsin L and B, peroxiredoxin, calmodulin, or glutathione S-transferase were recognized from the beginning to the end of the experimental infection, suggesting their potential role as immunomodulatory antigens. Furthermore, four FhES proteins (C2H2-type domain-containing protein, ferritin, superoxide dismutase, and globin-3) were identified for the first time as non-immunogenic proteins. These results may help to further understand host/parasite relationships in fasciolosis, and to identify potential diagnostic molecules and drug target candidates of F. hepatica.

18 June 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
ÓVÓscar Velasco-Rodríguez
Óscar Velasco-Rodríguez
MFMariana Fil
Mariana Fil
Tonje Marita Bjerkan HeggesetTonje Marita Bjerkan Heggeset
Tonje Marita Bjerkan Heggeset
KDKristin F. Degnes
Kristin F. Degnes
DBDavid Becerro-Recio
David Becerro-Recio
Carlos BarreiroCarlos Barreiro
Carlos Barreiro
Rotting wood is inhabited by a large diversity of bacteria, fungi, and insects with complex environmental relationships. The aim of this work was to study the composition of the microbiota (bacteria and fungi) in decaying wood from a northwest Spanish forest as a source of industrially relevant microorganisms. The analyzed forest is situated in a well-defined biogeographic area combining Mediterranean and temperate macrobioclimates. Bacterial diversity, determined by metagenome analyses, was higher than fungal heterogeneity. However, a total of 194 different cultivable bacterial isolates (mainly Bacillaceae, Streptomycetaceae, Paenibacillaceae, and Microbacteriaceae) were obtained, in contrast to 343 fungal strains (mainly Aspergillaceae, Hypocreaceae, and Coniochaetaceae). Isolates traditionally known as secondary metabolite producers, such as Actinobacteria and members of the Penicillium genus, were screened for their antimicrobial activity by the detection of antibiotic biosynthetic clusters and competitive bioassays against fungi involved in wood decay. In addition, the ability of Penicillium isolates to degrade cellulose and release ferulic acid from wood was also examined. These results present decaying wood as an ecologically rich niche and a promising source of biotechnologically interesting microorganisms.

Verified
Journal Article
Open access
PDF file
JSJudit Serrat
Judit Serrat
MTMaría Torres-Valle
María Torres-Valle
MGMarta López García
Marta López García
DBDavid Becerro-Recio
David Becerro-Recio
MSMar Siles-Lucas
Mar Siles-Lucas
JGJavier González-Miguel
Javier González-Miguel
Fasciola hepatica is the main causative agent of fasciolosis, a zoonotic parasitic disease of growing public health concern. F. hepatica metacercariae are ingested by the host and excyst in the intestine, thereby releasing the newly excysted juveniles (FhNEJ), which traverse the gut wall and migrate towards the biliary ducts. Since blocking F. hepatica development is challenging after crossing of the intestinal wall, targeting this first step of migration might result in increased therapeutic success. The intestinal extracellular matrix (ECM) is constituted by a network of structural proteins, including laminin (LM) and fibronectin (FN), that provide mechanical support while acting as physical barrier against intestinal pathogens. Here, we employed ELISA and immunofluorescent assays to test for the presence of LM- and FN-binding proteins on a tegument-enriched antigenic fraction of FhNEJ, and further determined their identity by two-dimensional electrophoresis coupled to mass spectrometry. Additionally, we performed enzymatic assays that revealed for the first time the capability of the juvenile-specific cathepsin L3 to degrade LM, and that LM degradation by FhNEJ proteins is further potentiated in the presence of host plasminogen. Finally, a proteomic analysis showed that the interaction with LM triggers protein changes in FhNEJ that may be relevant for parasite growth and adaptation inside the mammalian host. Altogether, our study provides valuable insights into the molecular interplay between FhNEJ and the intestinal ECM, which may lead to the identification of targetable candidates for the development of more effective control strategies against fasciolosis.

Verified
Journal Article
Open access
PDF file
JSJudit Serrat
Judit Serrat
CFClara Francés-Gómez
Clara Francés-Gómez
DBDavid Becerro-Recio
David Becerro-Recio
JGJavier González-Miguel
Javier González-Miguel
RGRon Geller
Ron Geller
MSMar Siles-Lucas
Mar Siles-Lucas
SARS-CoV-2, the causal agent of COVID-19, is a new coronavirus that has rapidly spread worldwide and significantly impacted human health by causing a severe acute respiratory syndrome boosted by a pulmonary hyperinflammatory response. Previous data from our lab showed that the newly excysted juveniles of the helminth parasite Fasciola hepatica (FhNEJ) modulate molecular routes within host cells related to vesicle-mediated transport and components of the innate immune response, which could potentially be relevant during viral infections. Therefore, the aim of the present study was to determine whether FhNEJ-derived molecules influence SARS-CoV-2 infection efficiency in Vero cells. Pre-treatment of Vero cells with a tegument-enriched antigenic extract of FhNEJ (FhNEJ-TEG) significantly reduced infection by both vesicular stomatitis virus particles pseudotyped with the SARS-CoV-2 Spike protein (VSV-S2) and live SARS-CoV-2. Pre-treatment of the virus itself with FhNEJ-TEG prior to infection also resulted in reduced infection efficiency similar to that obtained by remdesivir pre-treatment. Remarkably, treatment of Vero cells with FhNEJ-TEG after VSV-S2 entry also resulted in reduced infection efficiency, suggesting that FhNEJ-TEG may also affect post-entry steps of the VSV replication cycle. Altogether, our results could potentially encourage the production of FhNEJ-derived molecules in a safe, synthetic format for their application as therapeutic agents against SARS-CoV-2 and other related respiratory viruses.

17 July 2026 in Blood Cancer Journal
Verified
Journal Article
Open access
PDF file
ERElizabeta A. Rojas
Elizabeta A. Rojas
SCSara Cristóbal-Vargas
Sara Cristóbal-Vargas
DBDavid Becerro-Recio
David Becerro-Recio
CRCristina De Ramón
Cristina De Ramón
MCMyriam Cuadrado
Myriam Cuadrado
Norma C. GutiérrezNorma C. Gutiérrez
Norma C. Gutiérrez
TP53 gene alterations remain one of the major determinants of poor prognosis in multiple myeloma (MM). However, p53 dysfunction can also arise through non-genetic mechanisms, like post-translational modifications (PTMs). Indeed, phosphorylation and acetylation play essential roles in modulating p53 stability and activity, but their functional relevance in primary MM samples has not been systematically explored. Here, we quantified the expression of four key p53 PTMs, phosphorylation at S15, S20, and T55, and acetylation at K382, using capillary nanoimmunoassay, in 127 newly diagnosed MM patients. We also evaluated the DNA damage marker γ-H2AX, the kinase Chk2, and the phosphatases PP1A and PP2A-C. We found that p53 PTM expression was highly heterogeneous among patients. p-p53 T55 and Ac-p53 K382 were the most frequently expressed, detected in more than 70% of samples. Patients with double-hit TP53 showed significantly lower p-p53 S20 and p-p53 T55 levels compared with those with normal TP53. Low p53 phosphorylation at S20, S15 and T55 was correlated with higher progression risk (HR = 2.39, p = 0.02; HR = 2.14, p = 0.04; and HR = 2.13, p = 0.005, respectively). We also identified deregulated expression of Chk2 and phosphatases, suggesting upstream regulatory imbalances. This is the first study to quantify p53 PTMs in a large set of MM patients, revealing that post-translational dysregulation contributes to p53 impairment independently of TP53 gene alterations. Characterizing p53 PTMs sheds light on the mechanisms underlying its dysfunction, particularly in patients with an intact TP53 gene, but dysfunctional p53 protein regulation.